课题基金 / 基金详情

NUTROPIN RECOMBINANT HUMAN GROWTH HORMONE IN POST RENAL TRANSPLANTATION

NUTROPIN RECOMBINANT HUMAN GROWTH HORMONE IN POST RENAL TRANSPLANTATION
NUTROPIN 重组人类生长激素在肾移植后的应用
批准号：
6263654
负责人：
JOSEPH T FLYNN
金额：
$0.02万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6263654
关键词：
child (0-11) clinical research drug adverse effect hormone therapy human subject human therapy evaluation kidney transplantation pediatric pharmacology postoperative state recombinant proteins somatotropin

项目摘要

项目成果

JOSEPH T FLYNN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Poor growth in children with renal failure (CRF) may not be corrected with renal transplantation. Recombinant human growth hormone (rhGH), now in use to treat children with CRF pre-transplantation, may be effective post-transplantation as well, but may cause unique problems such as chronic rejection. This study is intended to study the efficacy and safety of rhGH treatment in this population.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NUTROPIN RECOMBINANT HUMAN GROWTH HORMONE IN POST RENAL TRANSPLANTATION
VITAMIN E IN TREATMENT OF IGA NEPHROPATHY IN CHILDREN
NUTROPIN RECOMBINANT HUMAN GROWTH HORMONE IN POST RENAL TRANSPLANTATION
PREDNISONE & FISH OIL SUPPLEMENTS IN CHILDREN & YOUNG ADULTS W/ IGA NEPHROLOGY
海外基金